Cambridge, UK | 21 May 2015
Isogenica is delighted to announce the strengthening of its management team with the appointment Dr Adam Collier as Director of Commercial Development.
Adam brings wide-ranging expertise in the pharmaceutical and biotech industry from senior business development positions at Ablynx nv, Astrazeneca-Medimmune PLC, Leiden University and Horizon Discovery Ltd, where he was Founder Business Development Director. In these roles, he led multi-disciplinary teams in all aspects of product and technology licensing, business development strategy, portfolio management, fundraising and general management.
Prior to embarking on his commercial career, Adam spent a significant period in public-sector and private-sector R&D, resulting in the publication of 11 peer-reviewed papers and the development of several small molecule therapeutics.
Adam holds a PhD in Virology from the University of Bath, and an MBA from the Judge Business School, University of Cambridge.